Yoko Furukawa-Hibi

8PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersHaematological tumoursWastewater treatment processesPharmacogenomicsNanoelectronics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 02, 2026
Eosinophil Proportion May Serve as a Candidate Biomarker for Adverse Events in Patients With Urothelial Carcinoma Treated With Enfortumab Vedotin.

|Jul 01, 2026
Elevation of Eosinophil Proportion After Pembrolizumab Increases the Risk of Immune-Related Adverse Events in Patients With Bladder Cancer.

|Apr 02, 2026
Time-saving impact of two generation model chemotherapy compounding robots on pharmacists' daily workflow: A long-term evaluation.

Yuki Tonogai, Masahiro Kondo, Yasuhiro Horita

|Feb 26, 2026
Sustained Drug-Drug Interaction Between Cyclosporine and Apalutamide in a Patient With Metastatic Hormone-Sensitive Prostate Cancer: A Case Report and Evaluation of CYP3A4 Induction via Pregnane X Receptor Activation by Apalutamide.

Yoshihisa Mimura, Takaomi Sanda, Rei Unno

|Jan 06, 2025
Prediction of Cisplatin-Induced Acute Kidney Injury Using an Interpretable Machine Learning Model and Electronic Medical Record Information.

Kaori Ambe, Yuka Aoki, Miho Murashima

|May 21, 2024
The Effects of a Red-Light Controllable Nitric Oxide Donor, NORD-1, on Erectile Dysfunction in Rats with Streptozotocin Induced Diabetes Mellitus.

Yuji Hotta, Kyoya Oyama, Takuma Yoshida

Pageof 2

Frequent Collaborators

4 joint publications

Taku Naiki

3 joint publications

Yosuke Sugiyama

3 joint publications

Noriyasu Kawai

2 joint publications

Yoshihisa Mimura